Synthesis of nitrogen heterocycles by the ring opening of pyridinium salts

Angewandte Chemie - International Edition

Volumn 45, Issue 46, 2006, Pages 7803-7806

  Kearney, Aaron M ^a   Vanderwal, Christopher D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biaryls; Cyclization; Indoles; Nitrogen heterocycles; Pyridinium salts

Indexed keywords

BIOCHEMISTRY; MEDICINE; SALTS; SUBSTITUTION REACTIONS; SULFUR COMPOUNDS; SYNTHESIS (CHEMICAL);

BIARYLS; CYCLIZATION; INDOLES; NITROGEN HETEROCYCLES; PYRIDINIUM SALTS;

NITROGEN COMPOUNDS;

HETEROCYCLIC COMPOUND; NITROGEN; PYRIDINIUM DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; SYNTHESIS;

HETEROCYCLIC COMPOUNDS; MOLECULAR STRUCTURE; NITROGEN; PYRIDINIUM COMPOUNDS;

EID: 33845314337     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200602996     Document Type: Article

References (26)

1. a) T. Zincke, Justus Liebigs Ann. Chem. 1903, 330, 361-374;
2. b) T. Zincke, Justus Liebigs Ann. Chem. 1904, 332, 296-345;
3. c) T. Zincke, W. Wurker, Justus Liebigs Ann. Chem. 1905, 338, 107-141;
4. d) W. König, J. Prakt. Chem. 1904, 69, 105-137.
5. For selected examples of reactions that occur without ring opening, see the following leading references: a) D. L. Comins, J. J. Sahn, Org. Lett. 2005, 7, 5227-5228;
6. b) E. J. Corey, Y. Tian, Org. Lett. 2005, 7, 5535-5537;
7. c) T. Focken, A. B. Charette, Org. Lett. 2006, 8, 2985-2988.
8. Please see the Supporting Information for plausible mechanisms for these transformations.
9. For reviews, please see : a) J. Becher, Synthesis 1980, 589-613;
10. b) W.-C. Cheng, M. J. Kurth, Org. Prep. Proced. Int. 2002, 34, 587-608;
11. c) C. M. Rojas in Name Reactions in Heterocyclic Chemistry (Ed.: J. J. Li), Wiley, Hoboken, 2005, pp. 355-374.
12. Also, see J. Becher, L. Finsen, I. Winckelmann, Tetrahedron 1981, 37, 2375-2378.
13. a) For applications of these compounds in the dye industry, see: A. Mishra, R. K. Behera, P. K. Behera, B. K. Mishra, G. B. Behera, Chem. Rev. 2000, 100, 1973-2011;
14. b) For a two-step azulene synthesis featuring 5-amino-2,4-pentadienals, see: K. Hafner, K.-D. Asmus, Justus Liebigs Ann. Chem. 1964, 671, 31-40;
15. c) For one application in natural product synthesis, see: K. Jakubowicz, K. B. Abdeljelil, M. Herdemann, M.-T. Martin, A. Gateau-Olesker, A. A. Mourabit, C. Marazano, B. C. Das, J. Org. Chem. 1999, 64, 7381-7387.
16. For a comprehensive review of methods for indole synthesis, see: J. A. Joule, Sci. Synth. 2001, 10, 361-652.
17. Selected recent indole syntheses: a) T. J. Greshock, R. L. Funk, J. Am. Chem. Soc. 2006, 128, 4946-4947;
18. b) D. F. Taber, W. Tian, J. Am. Chem. Soc. 2006, 128, 1058-1059, and references therein.
19. For a review, see: A. Suzuki in Modern Arene Chemistry (Ed.: D. Astruc), Wiley-VCH, Weinheim, 2002, pp. 53-106. Please see the Supporting Information for experimental details.
20. Typical activating agents include 2,4-dinitrochlorobenzene, cyanogen halides, and sulfur trioxide. See references [1] and [4a].
21. The conversion of 9 into 10 could conceivably occur through an electrocyclic pathway or a simple ionic mechanism; either would be followed by simple alkene geometrical isomerizations.
22. Y. Huang, A. M. Walji, C. H. Larsen, D. W. C. MacMillan, J. Am. Chem. Soc. 2005, 127, 15 051-15 053, and references therein. Although we suspect that the reactivity of products of type 7 will almost certainly be different from regular α,β-unsaturated aldehydes owing to the conjugation of the indole nitrogen, the incorporation of an electron-withdrawing N-protecting group might result in reasonable reactivity in iminium-based asymmetric organocatalysis. For a relevant example, please see reference [12].
23. An indole-3-propenal was used in an asymmetric organocatalytic Diels-Alder reaction in a synthesis of hapalindole Q: A. C. Kinsman, M. A. Kerr, J. Am. Chem. Soc. 2003, 125, 14 120-14 125.
24. For a few select examples, see: Neurological therapy: a) N. R. Curtis, J. J. Kulagowski, P. D. Leeson, M. P. Ridgill, F. Emms, S. B. Freedman, S. Patel, S. Patel, Bioorg. Med. Chem. Lett. 1999, 9, 585-588;
25. b) G. A. Showell, F. Emms, R. Marwood, D. O'Connor, S. Patel, P. D. Leeson, Bioorg. Med. Chem. 1998, 6, 1-8;
26. Antiviral therapy: c) T. Wang, Z. Zhang, O. B. Wallace, M. Deshpande, H. Fang, Z. Yang, L. M. Zadjura, D. L. Tweedie, S. Huang, F. Zhao, S. Ranadive, B. S. Robinson, Y.-F. Gong, K. Ricarrdi, T. P. Spicer, C. Deminie, R. Rose, H.-G. H. Wang, W. S. Blair, P.-Y. Shi, P.-f. Lin, R. J. Colonno, N. A. Meanwell, J. Med. Chem. 2003, 46, 4236-4239.